Check the boxes for common signs exhibited in dogs with separation anxiety to see if your dog might be suffering from this manageable disorder.
IMPORTANT SAFETY INFORMATION: The most common adverse events reported in decreasing order of reported frequency are: decreased appetite, depression/lethargy, shaking/shivering/tremor, vomiting, restlessness and anxiety, seizures, aggression, diarrhea, dilated pupils, vocalization, weight loss, panting, confusion, incoordination, and excessive salivation. Reconcile chewable tablets are contraindicated for dogs with a history of seizures or when used with drugs that may cause seizures. Consult your veterinarian for complete safety information or click here to read the package insert.
The information, tools and material presented on this site are provided for informational and educational purposes only. Please consult your veterinarian for an official diagnosis of canine separation anxiety and to learn more about Reconcile. Click here to read the complete terms and conditions regarding use of this web site.
Reconcile® is a registered trademark and PRN™ is a trademark of Pegasus Laboratories, Inc.